Pfizer Inc
Close on Nov 2, 2026Market cap $174.81BP/E 40.4Yield 5.61%
Pfizer Non-GAAP Adjusted Income Attributable to Pfizer Common by Year
Non-GAAP Adjusted Income Attributable to Pfizer Common Shareholders ($M) ($M)
Pfizer Non-GAAP Adjusted Income Attributable to Pfizer Common: $18,406M in FY2025, up 3.9% from a year earlier.
Where the FY2025 figure comes from
“|| Adjusted (3) Income | 3,786 | 3,592 | 5% | 18,406 | 17,716 | 4%”
Source: Form 8-K (Earnings / Guidance Release) (pfe-12312025xex99.htm, filed 2026-02-03) ↗
Reported in Form 8-K Non-GAAP Reconciliation Tables.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up non-GAAP Adjusted Income Attributable to Pfizer Common
Cite this data
StockData. (2026). Pfizer Non-GAAP Adjusted Income Attributable to Pfizer Common ($M), annual FY2016–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/adj-income
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.